67 studies found for:    Raynaud's
Show Display Options
RSS Create an RSS feed from your search for:
Raynaud's
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Prospective Multicenter Study on the Identification of Genetic Abnormalities Predisposing to Vasospasm From a Privileged Model: the Primary Raynaud's Phenomenon
Conditions: Primary Raynaud's Phenomenon (PR);   Genetic Mutations Causing PR;   Study of Patients and Their Relatives (With or Without Primary PR)
Intervention: Genetic: Demonstration of genetic mutations causing Raynaud's phenomenon
2 Completed PF-00489791 For The Treatment Of Raynaud's
Conditions: Raynaud's Disease;   Peripheral Vascular Disease
Intervention: Drug: PF-00489791
3 Unknown  A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon
Conditions: Raynaud's Disease;   Raynaud's Disease Secondary to Scleroderma;   Raynaud's Disease Secondary to Other Autoimmune Disease
Interventions: Drug: Nitroglycerin;   Drug: Topical AmphiMatrix
4 Completed Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon
Condition: Raynaud's Disease
Intervention: Drug: Topical organogel with nitroglycerin
5 Unknown  Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms
Condition: Raynaud Disease
Interventions: Drug: 0.9% nitroglycerin in TAM cream;   Drug: vehicle cream
6 Recruiting "As Required" Oral Sildenafil in Raynaud's Phenomenon
Condition: Raynaud's Phenomenon
Interventions: Drug: Sildenafil 40 mg;   Drug: Sildenafil 80 mg;   Drug: Placebo
7 Not yet recruiting Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome
Conditions: Scleroderma;   Raynaud's Syndrome
Interventions: Drug: Onabotulinumtoxin A;   Drug: sterile saline solution
8 Completed Dose Response to Topical Glyceryl Trinitrate in Patients With Raynaud's Phenomenon
Condition: Raynaud's Phenomenon
Interventions: Drug: placebo cream;   Drug: Glyceryl Trinitrate
9 Completed Dose Response Study of a Topical Gel for the Treatment of Raynaud's Phenomenon
Conditions: Raynaud's Disease;   Raynaud's Disease Secondary to Scleroderma;   Raynaud's Disease Secondary to Autoimmune Disease
Intervention: Drug: MQX-503
10 Completed Acupressure for the Treatment of Raynaud's Phenomenon
Condition: Primary Raynaud's Phenomeon
Interventions: Other: Acupressure;   Other: Acupressure dilatation;   Behavioral: education
11 Completed Tadalafil for the Treatment of Raynaud's
Condition: Raynaud
Intervention: Drug: Tadalafil
12 Completed Lab Study of MQX-503 in Treatment of Raynaud's
Conditions: Raynaud Disease;   Raynaud Disease Secondary to Scleroderma;   Raynaud Secondary to Other Autoimmune Disease
Intervention: Drug: topical organogel with nitroglycerin
13 Completed Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon
Conditions: Raynaud's Disease;   Scleroderma;   Autoimmune Diseases
Intervention: Drug: Topical AmphiMatrix with nitroglycerin (MQX-503)
14 Completed A Randomized Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma
Conditions: Raynaud's Phenomenon;   Digital Ulcers;   Scleroderma
Interventions: Drug: Tadalafil;   Drug: Placebo
15 Completed Randomised Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma
Condition: Raynaud Disease
Intervention: Drug: Tadalafil
16 Completed Dose Response Study of a Topical Formulation of Nitroglycerin for the Treatment of Raynaud's Phenomenon
Condition: Raynaud's Disease
Intervention: Drug: Nitroglycerin
17 Completed
Has Results
Botulinum Toxin in the Treatment of Raynaud's
Condition: Raynaud's Syndrome
Intervention: Drug: botulinum toxin A
18 Completed Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator
Condition: Raynaud Disease
Interventions: Drug: Riociguat (Adempas, BAY63-2521);   Drug: Placebo
19 Completed Safety, Tolerability, and Pharmacodynamic Profile of Oral 2101 in Secondary Raynaud's Disease
Condition: Raynaud's Disease
Intervention: Drug: SLx-2101
20 Completed The Effect of Physical Therapy on Raynaud`s Phenomenon Secondary to Systemic Sclerosis
Conditions: Raynaud's Phenomenon;   Systemic Sclerosis
Interventions: Other: Biofeedback;   Other: Deep oscillation

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years